How RxManager produces and reviews its content.

We ground content in public, authoritative sources, including government and regulatory materials (such as CMS and FDA), published research, and primary contract and filing documents. We describe how a rule or mechanism works rather than asserting specifics we cannot support.

Material intended for publication is reviewed before it is published. We aim to distinguish clearly between what a statute or rule states, what is common industry practice, and what is our own analysis.

RxManager is pro-transparency, not anti-PBM. We are not sponsored by any PBM, broker, or manufacturer, and we do not accept payment to feature or favor any vendor. No pay-for-placement.

If something is inaccurate or out of date, tell us through the contact page and we will review and correct it. RxManager is in early access; pages are updated as the product and the regulatory landscape evolve.